Stefano Pallanti is a psychiatry professor at Stanford University, director of the first Applied Precision Medicine program on ADHD life span, a brain stimulation team member, an executive committee fellow, the Scientific Board of European College of Neuropsychopharmacology fellow of the American Psychiatric Association, a DSM- Advisor for the OCD Spectrum workgroup, a founder of the Clinical TMS Society, an honorary professor at Mount Sinai Hospital, Albert Einstein Hospital and Imperial College, and a tenured professor at Florence University.

As PI and co-PI of over ten funded studies, he currently conducts a 2017–2019 NIMH R21 grant modulating inhibitory control networks in gambling disorder with Theta Burst Stimulation. He is director of the Istituto di Neuroscienze Firenze. He has authored 173 papers on peer-reviewed journals and 14 books, including a manual for the APP. His H INDEX is 50.